Institute for Basic Science

The Catholic University of Korea Industry-academic

Wisconsin Alumni Research Foundation

Snur & Db Foundation

Snr R&db Foundation

Sin-Jung Park

Taeghwan Hyeon

Kun Na

Daishun Ling

Byung Hyo Kim

Wooram Park

Hyeona Yim

Yong Sun Jeon

Kyoung Sub Kim

Yang Lu

Michael J Hackett

Seungpyo Hong

Described herein are hybrid nanoparticles that are exosomes loaded with one or more nanoparticle dendrimers. Also included are pharmaceutical compositions including the hybrid nanoparticles and methods of making the hybrid nanoparticles. Also described is a method of treating a human subject by administering to the human subject the above-described hybrid nanoparticles.

Dendrimer-exosome hybrid nanoparticles as a delivery platform

The present invention relates to a nanoformulated self-assembled pharmaceutical composition for photodynamic therapy. More particularly, the present invention is directed to a self-assembled pharmaceutical composition for photodynamic therapy comprising a photosensitizer, a ligand A which is separated at a specific pH range, and a ligand B of which surface charge changes at a specific pH range and a method for manufacturing the same.

Self-assembled pharmaceutical composition for photodynamic therapy

The present invention relates to MRI contrasting agent for contrasting cancer cell which contains ultrafine nanoparticles. More particularly, the present invention is directed to a self-assembled ligand composition comprising a ligand A, which is separated at a specific pH range, and a ligand B of which surface charge changes at a specific pH range, MRI contrast agent for contrasting cancer cell comprising said ligand composition and MRI contrasting nanoparticles, and the methods for preparing them.

MRI contrasting agent for contrasting cancer cell

Growing community of inventors

Seoul, South Korea

Sin-Jung Park